Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Preferred Dividend Payments (2016 - 2019)

Outlook Therapeutics (OTLK) has disclosed Preferred Dividend Payments for 5 consecutive years, with $166133.0 as the latest value for Q4 2019.

  • Quarterly Preferred Dividend Payments rose 10.38% to $166133.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $328214.0 through Jun 2020, down 47.63% year-over-year, with the annual reading at $166133.0 for FY2020, 73.42% down from the prior year.
  • Preferred Dividend Payments for Q4 2019 was $166133.0 at Outlook Therapeutics, up from $162081.0 in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $1.1 million in Q2 2015, with the low at -$1.9 million in Q3 2015.
  • Average Preferred Dividend Payments over 5 years is $294585.5, with a median of $166133.0 recorded in 2019.
  • The sharpest move saw Preferred Dividend Payments surged 1423.54% in 2016, then tumbled 75.77% in 2019.
  • Over 5 years, Preferred Dividend Payments stood at $939539.0 in 2015, then plummeted by 47.51% to $493207.0 in 2016, then decreased by 8.6% to $450801.0 in 2017, then plummeted by 66.61% to $150508.0 in 2018, then increased by 10.38% to $166133.0 in 2019.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods came in at $166133.0, $162081.0, and $158128.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.